Allergy Therapeutics plc

AGYTF · OTC
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Operating Activities
Net Income-$39-$39-$42-$13
Dep. & Amort.$4$4$4$4
Deferred Tax$0$0$0-$0
Stock-Based Comp.$1$1$0$0
Change in WC-$3-$0$5-$6
Other Non-Cash-$2$2$4$0
Operating Cash Flow-$39-$32-$29-$14
Investing Activities
PP&E Inv.-$3-$3-$5-$3
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0-$0-$0
Inv. Sales/Matur.$0$2$0$0
Other Inv. Act.-$1$0$0$0
Investing Cash Flow-$4-$1-$5-$3
Financing Activities
Debt Repay.$35$34$25-$1
Stock Issued$0$2$6$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$9-$5-$4-$2
Financing Cash Flow$44$31$28-$3
Forex Effect$1-$0$0$0
Net Chg. in Cash$1-$2-$6-$20
Supplemental Information
Beg. Cash$16$15$21$40
End Cash$18$13$15$21
Free Cash Flow-$44-$36-$34-$18
Allergy Therapeutics plc (AGYTF) Financial Statements & Key Stats | AlphaPilot